ICD-9-CM

795 Other and nonspecific abnormal cytological, histological, immunological and DNA test findings Excludes: abnormal cytologic smear of anus and anal HPV (796.70-796.79) nonspecific abnormalities of red blood cells (790.01-790.09)
795.0: Abnormal Papanicolaou smear of cervix and cervical HPV Abnormal thin preparation smear of cervix Abnormal cervical cytology Excludes: abnormal cytologic smear of vagina and vaginal HPV (795.10-795.19) carcinoma in situ of cervix (233.1) cervical intraepithelial neoplasia I (CIN I) (622.11) cervical intraepithelial neoplasia II (CIN II) (622.12) cervical intraepithelial neoplasia III (CIN III) (233.1) dysplasia (histologically confirmed) of cervix (uteri) NOS (622.10) mild cervical dysplasia (histologically confirmed) (622.11) moderate cervical dysplasia (histologically confirmed) (622.12) severe cervical dysplasia (histologically confirmed) (233.1)
795.1: Abnormal Papanicolaou smear of vagina and vaginal HPV Abnormal thin preparation smear of vagina NOS Abnormal vaginal cytology NOS Use additional code to identify acquired absence of uterus and cervix, if applicable (V88.01-V88.03) Excludes: abnormal cytologic smear of cervix and cervical HPV (795.00-795.09) carcinoma in situ of vagina (233.31) carcinoma in situ of vulva (233.32) dysplasia (histologically confirmed) of vagina NOS (623.0, 233.31) dysplasia (histologically confirmed) of vulva NOS (624.01, 624.02, 233.32) mild vaginal dysplasia (histologically confirmed) (623.0) mild vulvar dysplasia (histologically confirmed) (624.01) moderate vaginal dysplasia (histologically confirmed) (623.0) moderate vulvar dysplasia (histologically confirmed) (624.02) severe vaginal dysplasia (histologically confirmed) (233.31) severe vulvar dysplasia (histologically confirmed) (233.32) vaginal intraepithelial neoplasia I (VAIN I) (623.0) vaginal intraepithelial neoplasia II (VAIN II) (623.0) vaginal intraepithelial neoplasia III (VAIN III) (233.31) vulvar intraepithelial neoplasia I (VIN I) (624.01) vulvar intraepithelial neoplasia II (VIN II) (624.02) vulvar intraepithelial neoplasia III (VIN III) (233.32)
795.2: Nonspecific abnormal findings on chromosomal analysis Abnormal karyotype
795.3: Nonspecific positive culture findings Positive culture findings in: nose sputum throat wound Excludes: that of: blood (790.7-790.8) urine (791.9)
795.4: Other nonspecific abnormal histological findings
795.5: Nonspecific reaction to test for tuberculosis
795.6: False positive serological test for syphilis False positive Wassermann reaction
795.7: Other nonspecific immunological findings Excludes: abnormal tumor markers (795.81-795.89) elevated prostate specific antigen [PSA] (790.93) elevated tumor associated antigens (795.81-795.89) isoimmunization, in pregnancy (656.1-656.2) affecting fetus or newborn (773.0-773.2)
795.8: Abnormal tumor markers Elevated tumor associated antigens [TAA] Elevated tumor specific antigens [TSA] Excludes: elevated prostate specific antigen [PSA] (790.93)

795 Other and nonspecific abnormal cytological, histological, immunological and DNA test findings

Excludes:

abnormal cytologic smear of anus and anal HPV (796.70-796.79)

nonspecific abnormalities of red blood cells (790.01-790.09)

795.0: Abnormal Papanicolaou smear of cervix and cervical HPV

Abnormal thin preparation smear of cervix

Abnormal cervical cytology

Excludes:

abnormal cytologic smear of vagina and vaginal HPV (795.10-795.19)

carcinoma in situ of cervix (233.1)

cervical intraepithelial neoplasia I (CIN I) (622.11)

cervical intraepithelial neoplasia II (CIN II) (622.12)

cervical intraepithelial neoplasia III (CIN III) (233.1)

dysplasia (histologically confirmed) of cervix (uteri) NOS (622.10)

mild cervical dysplasia (histologically confirmed) (622.11)

moderate cervical dysplasia (histologically confirmed) (622.12)

severe cervical dysplasia (histologically confirmed) (233.1)

795.1: Abnormal Papanicolaou smear of vagina and vaginal HPV

Abnormal thin preparation smear of vagina NOS

Abnormal vaginal cytology NOS

Use additional code to identify acquired absence of uterus and cervix, if applicable (V88.01-V88.03)

Excludes:

abnormal cytologic smear of cervix and cervical HPV (795.00-795.09)

carcinoma in situ of vagina (233.31)

carcinoma in situ of vulva (233.32)

dysplasia (histologically confirmed) of vagina NOS (623.0, 233.31)

dysplasia (histologically confirmed) of vulva NOS (624.01, 624.02, 233.32)

mild vaginal dysplasia (histologically confirmed) (623.0)

mild vulvar dysplasia (histologically confirmed) (624.01)

moderate vaginal dysplasia (histologically confirmed) (623.0)

moderate vulvar dysplasia (histologically confirmed) (624.02)

severe vaginal dysplasia (histologically confirmed) (233.31)

severe vulvar dysplasia (histologically confirmed) (233.32)

vaginal intraepithelial neoplasia I (VAIN I) (623.0)

vaginal intraepithelial neoplasia II (VAIN II) (623.0)

vaginal intraepithelial neoplasia III (VAIN III) (233.31)

vulvar intraepithelial neoplasia I (VIN I) (624.01)

vulvar intraepithelial neoplasia II (VIN II) (624.02)

vulvar intraepithelial neoplasia III (VIN III) (233.32)

795.3: Nonspecific positive culture findings

Positive culture findings in:

nose

sputum

throat

wound

Excludes:

that of:

blood (790.7-790.8)

urine (791.9)

795.6: False positive serological test for syphilis

False positive Wassermann reaction

795.7: Other nonspecific immunological findings

Excludes:

abnormal tumor markers (795.81-795.89)

elevated prostate specific antigen [PSA] (790.93)

elevated tumor associated antigens (795.81-795.89)

isoimmunization, in pregnancy (656.1-656.2)

affecting fetus or newborn (773.0-773.2)

795.8: Abnormal tumor markers

Elevated tumor associated antigens [TAA]

Elevated tumor specific antigens [TSA]

Excludes:

elevated prostate specific antigen [PSA] (790.93)